Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Sanofi’s Lantus Doubled Risk of Cancer in Study of Diabetics
Sanofi’s Lantus Doubled Risk of Cancer in Study of Diabetics
Sanofi’s Lantus Doubled Risk of Cancer in Study of Diabetics
Submitted by
admin
on December 6, 2011 - 7:45pm
Source:
Bloomberg
News Tags:
diabetes
Lantus
Sanofi
metformin
insulin
Headline:
Sanofi’s Lantus Doubled Risk of Cancer in Study of Diabetics
Do Not Allow Advertisers to Use My Personal information
